MAPT and Alzheimer disease: This approach preserves donor-specific age signatures, allowing the resulting neurons to mimic key neuropathological features of late onset AD, including extracellular amyloid-β deposition, tau aggregation, dystrophic neurite formation, and neuronal loss.